Form 8-K - Current report:
SEC Accession No. 0001104659-25-043508
Filing Date
2025-05-01
Accepted
2025-05-01 16:01:21
Documents
14
Period of Report
2025-04-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2513718d1_8k.htm   iXBRL 8-K 27169
  Complete submission text file 0001104659-25-043508.txt   249108

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA abt-20250425.xsd EX-101.SCH 3368
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abt-20250425_def.xml EX-101.DEF 27978
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE abt-20250425_lab.xml EX-101.LAB 37450
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abt-20250425_pre.xml EX-101.PRE 26202
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2513718d1_8k_htm.xml XML 5628
Mailing Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500
Business Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500 2246676100
ABBOTT LABORATORIES (Filer) CIK: 0000001800 (see all company filings)

EIN.: 360698440 | State of Incorp.: IL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-02189 | Film No.: 25902848
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)